AIDS

1. SHALEV N, van Sighem AI, Bezemer DO, Juuriaans S, et al
   Cabotegravir and rilpivirine resistance-associated mutations among people with newly diagnosed HIV-1 in the Netherlands.
   AIDS. 2026 Jun 26. doi: 10.1097/QAD.0000000000004570.
   

   >> Share

   
   
2. AWWAD A, Das Adhikari U, Burdo TH, Baak S, et al
   Pitavastatin effect on enterocyte injury markers in an ART treated HIV population: Insights from REPRIEVE.
   AIDS. 2026 Jun 26. doi: 10.1097/QAD.0000000000004572.
   

   >> Share

   
   
3. GERVASONI C, Cossu MV, Giacomelli A, Iannone V, et al
   Blood pressure control in people with HIV and established atherosclerotic cardiovascular disease: a real-world descriptive analysis.
   AIDS. 2026;40:1216-1217.
   

   >> Share

   
   
4. TITANJI BK, Dabbs-Brown A, Mather JT, Hui Q, et al
   Genome-wide association study of cardiovascular disease in people with HIV from the Million Veteran Program (MVP).
   AIDS. 2026;40:1212-1215.
   

   >> Share

   
   
5. LAPADULA G, Soria A, Puoti M, Bonfanti P, et al
   Occult hepatitis B and risk of reactivation following switch to non-hepatitis B virus-active antiretroviral therapy in people with HIV.
   AIDS. 2026;40:1053-1066.
   

   >> Share

   
   
6. VOTSIKA V, Mohan S, Phillips A, Colbourn T, et al
   The Potential Impact of Reduced Donor Funding for HIV Programs on Malawi's Disease Burden.
   AIDS. 2026 Jun 16. doi: 10.1097/QAD.0000000000004568.
   

   >> Share

   
   

   
   AIDS Res Hum Retroviruses

7. GE Z, Liu D, Zhong H, Niu Z, et al
   Near Full-Length Genome Characterization of a Novel Second-Generation HIV-1 CRF01_AE/CRF07_BC Recombinant Identified in an MSM Individual in Guizhou, China.
   AIDS Res Hum Retroviruses. 2026 Jun 23:8892229261463837.
   

   >> Share

   
   

   
   BMC Cancer

8. LEMA TF
   Epidemiology of pre-cancerous cervical lesions among women in Adama, Ethiopia.
   BMC Cancer. 2026 Jun 26. doi: 10.1186/s12885-026-16413.
   

   >> Share

   
   

   
   BMC Immunol

9. PAN K, Wubuli M, Zhang T, Fan S, et al
   Analysis of the clinical characteristics of poor immunological reconstitution in AIDS patients after long-term antiviral therapy in Xinjiang, China.
   BMC Immunol. 2025;26:48.
   

   >> Share

   
   

   
   BMJ

10. WARIS A, Kavanagh MM
    Action for a healthier global tax system.
    BMJ. 2026;393:e343297.
    

    >> Share

    
    

    
    Clin Infect Dis

11. HORBERG M, Thompson M, Agwu A, Colasanti J, et al
    Clarification to HIVMA/IDSA HIV Primary Care Guidance Immunization Recommendations.
    Clin Infect Dis. 2026 Jun 24:ciag384. doi: 10.1093.
    

    >> Share

    
    

    
    Dermatology

12. SAKUNCHOTPANIT G, Chen R, Ortiz Lopez LI, Akbik M, et al
    Mpox Outbreaks Beyond Historically Endemic Regions: A Clinical Review of Vaccination Strategies and Public Health Challenges.
    Dermatology. 2026 Jun 25:1-26. doi: 10.1159/000552313.
    

    >> Share

    
    

    
    HIV Med

13. GUEUNING C, Brizmohun M, Dauby N, Martin C, et al
    Ultrasound for the determination of appropriate needle length for intragluteal injection of long-acting rilpivirine-cabotegravir.
    HIV Med. 2026 Jun 22. doi: 10.1111/hiv.70272.
    

    >> Share

    
    
14. 
    Correction to 'Pharmacovigilance study of INSTIs associated with weight gain and glucose/lipid metabolism adverse events based on the FDA adverse event reporting system'.
    HIV Med. 2026 Jun 26. doi: 10.1111/hiv.70274.
    

    >> Share

    
    

    
    J Acquir Immune Defic Syndr

15. MORSICA G, Lolatto R, Diotallevi S, Svicher V, et al
    Hepatitis B Reactivation in People with HIV After Switching to a 2-Drug Anti-HBV Sparing Regimen.
    J Acquir Immune Defic Syndr. 2026 Jun 23. doi: 10.1097/QAI.0000000000003921.
    

    >> Share

    
    
16. APPA A, Javanbakht M, Spinelli M, Heise MJ, et al
    Hair Testing to Detect Long-term Methamphetamine Use in People Living with and without HIV.
    J Acquir Immune Defic Syndr. 2026 Jun 22. doi: 10.1097/QAI.0000000000003918.
    

    >> Share

    
    
17. LEWIS L, Sookrajh Y, van der Molen J, Khubone T, et al
    Indirect effects of HIV differentiated service delivery programmes on quality of clinic care: a retrospective cohort study of clients starting antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2026 Jun 22. doi: 10.1097/QAI.0000000000003916.
    

    >> Share

    
    
18. ROSEN JG, Offorjebe OA, Ngila B, Kinuthia J, et al
    Anticipated Determinants and Strategies Supporting Same-Day HIV Pre-Exposure Prophylaxis Implementation During Emergency Care Encounters in Kenya: A Qualitative Study.
    J Acquir Immune Defic Syndr. 2026 Jun 22. doi: 10.1097/QAI.0000000000003910.
    

    >> Share

    
    
19. OFFORJEBE OA, Ochola E, Ngila B, Kinuthia J, et al
    Eligibility and Acceptability of Same-Day HIV Pre-Exposure Prophylaxis Initiation During Emergency Care Encounters in Nairobi, Kenya: A Cross-Sectional Study.
    J Acquir Immune Defic Syndr. 2026 Jun 26. doi: 10.1097/QAI.0000000000003911.
    

    >> Share

    
    
20. VAN DER MOLEN J, Tlhaku K, Lewis L, Sookrajh Y, et al
    Earlier referral to differentiated antiretroviral therapy delivery at six months after initiation: a retrospective cohort study in KwaZulu-Natal, South Africa.
    J Acquir Immune Defic Syndr. 2026 Jun 16. doi: 10.1097/QAI.0000000000003917.
    

    >> Share

    
    
21. FORER R, Clark JL, Gutierrez J, Segura E, et al
    Unpacking "High-Risk": A Latent Class Analysis of Sexual Partnership Patterns and HIV Transmission Risk Among Gay, Bisexual, and other Men who have Sex with Men in Peru.
    J Acquir Immune Defic Syndr. 2026 Apr 27. doi: 10.1097/QAI.0000000000003893.
    

    >> Share

    
    
22. FENG X, Nakigozi G, Patel EU, Kennedy CE, et al
    HIV seroprevalence, incidence, and viral suppression among Ugandan female bar workers: a population-based study.
    J Acquir Immune Defic Syndr. 2026 Jun 26. doi: 10.1097/QAI.0000000000003908.
    

    >> Share

    
    
23. TORGERSEN J, Newcomb CW, Carbonari DM, Rentsch CT, et al
    Evaluating Associations Between Cumulative Use of Chronic Liver Injury-Inducing Antiretroviral Therapy and Hepatocellular Carcinoma, By Chronic Liver Disease Status.
    J Acquir Immune Defic Syndr. 2026 Jun 26. doi: 10.1097/QAI.0000000000003923.
    

    >> Share

    
    
24. BHARDWAJ S, Mugisha J, Magembe J, Eram G, et al
    Men's preferences for HIV self-test distribution strategies in Uganda: A discrete choice experiment.
    J Acquir Immune Defic Syndr. 2026 Jun 26. doi: 10.1097/QAI.0000000000003922.
    

    >> Share

    
    
25. TOLLEFSON D, Lankowski A, Dasgupta S, Kazmirak C, et al
    Preferences for HIV testing among partners of transgender women in Lima, Peru: a discrete choice experiment.
    J Acquir Immune Defic Syndr. 2026 May 28. doi: 10.1097/QAI.0000000000003909.
    

    >> Share

    
    
26. RIVERA AV, Pathela P, Rodriguez K, Edelstein Z, et al
    Trends in sexually transmitted infections by PrEP use among cisgender men who have sex with men in New York City, 2014-2023.
    J Acquir Immune Defic Syndr. 2026 Apr 27. doi: 10.1097/QAI.0000000000003891.
    

    >> Share

    
    
27. WOLDEMESKEL M, Unternaher J, Munger O, Williams T, et al
    Birth and Infant Growth Outcomes Following Prenatal Exposure to Bictegravir.
    J Acquir Immune Defic Syndr. 2026 May 28. doi: 10.1097/QAI.0000000000003912.
    

    >> Share

    
    
28. YANG C, Shi L, Wei C, Martinez O, et al
    Mapping risk and opportunity: A space-based affiliation network analysis of physical and virtual spaces among high risk men.
    J Acquir Immune Defic Syndr. 2026 Jun 16. doi: 10.1097/QAI.0000000000003919.
    

    >> Share

    
    
29. FAHEY CA, Whitney BM, Drumright LN, Mehta SH, et al
    Association between housing instability and HIV care outcomes among people with HIV in the United States.
    J Acquir Immune Defic Syndr. 2026 May 19. doi: 10.1097/QAI.0000000000003906.
    

    >> Share

    
    
30. JEETOO M, Yeo YR, Charles DL, Moll AP, et al
    Cost-effectiveness of reducing HIV infections through screening and treating alcohol use and depression in KwaZulu-Natal, South Africa: a mathematical modeling study.
    J Acquir Immune Defic Syndr. 2026 Jun 16. doi: 10.1097/QAI.0000000000003920.
    

    >> Share

    
    
31. BIEN-GUND C, Gross R, Williams J, Brady KA, et al
    Lower self-efficacy and lower PrEP stigma predict telePrEP preferences among HIV self-testers.
    J Acquir Immune Defic Syndr. 2026 Jun 2. doi: 10.1097/QAI.0000000000003913.
    

    >> Share

    
    

    
    J Am Acad Dermatol

32. AKISKA YM, Rakhmanina N, Friedman A
    Response to van Rooij et al., "Clinical Context and Comparative Interpretation of Dermatologic Disease Burden in People With HIV in the Modern Antiretroviral Era".
    J Am Acad Dermatol. 2026 Jun 26:S0190-9622(26)03001.
    

    >> Share

    
    

    
    J Infect Dis

33. CHENGSUPANIMIT T
    A Tribute to Our Mentors.
    J Infect Dis. 2026 Jun 25:jiag330. doi: 10.1093.
    

    >> Share

    
    

    
    J Virol

34. BERMEJO-JAMBRINA M, Pauzuolis M, Kimpel J, Gerold G, et al
    Double trouble: how co- and superinfections shape viral dynamics and host responses.
    J Virol. 2026 Jun 23:e0205525. doi: 10.1128/jvi.02055.
    

    >> Share

    
    

    
    Lancet Infect Dis

35. HASEGAWA S, Teran-Garza F, Meier JL
    Disseminated herpes zoster with hepatic necrosis in a patient with newly diagnosed HIV.
    Lancet Infect Dis. 2026;26:e335-e336.
    

    >> Share

    
    

    
    N Engl J Med

36. FALCONER J, Bekker LG, Jarvis JN
    Long-Acting Treatment and Advanced HIV Disease - Addressing a Public Health Priority.
    N Engl J Med. 2026 Jun 24. doi: 10.1056/NEJMp2605547.
    

    >> Share

    
    
37. CONRADIE F, Badat T, Poswa A, Rajaram S, et al
    A Pragmatic Trial of a 6-Month Strategy for Rifampicin-Resistant Tuberculosis.
    N Engl J Med. 2026;394:2429-2439.
    

    >> Share

    
    

    
    PLoS One

38. THEOPHIL M, Lyimo AA, Ambikile JS
    Chronic kidney disease screening and associated factors among people living with HIV on anti-retroviral therapy in Dar Es Salaam, Tanzania: Hospital-based cross-sectional study.
    PLoS One. 2026;21:e0352024.
    

    >> Share

    
    
39. OSAYI EO, Blake SC, Ngwoke K, Pius C, et al
    Mother to child transmission of HIV in Plateau State, Nigeria: Case-based surveillance of the HIV infected HIV-exposed infants.
    PLoS One. 2026;21:e0350012.
    

    >> Share

    
    
40. MUKUBESA C, Siame L, Malumani M, Nkole F, et al
    Predictors of tuberculosis mortality among patients on treatment: A retrospective cohort study at a rural general hospital in Zambia.
    PLoS One. 2026;21:e0345056.
    

    >> Share

    
    
41. TAO K, Satija R, Zhou J, Osman ZA, et al
    Fine-tuning and structured prompting strategies for question answering over full-text biomedical research articles.
    PLoS One. 2026;21:e0351631.
    

    >> Share

    
    
42. WONGNAAH FG, Adeleye K, Osborne A, Aboagye RG, et al
    Self-reported sexually transmitted infections and related symptoms among women in Ghana.
    PLoS One. 2026;21:e0348770.
    

    >> Share

    
    
43. OTIENDE VA, Achia TN, Mwambi HG
    Correction: Bayesian hierarchical modeling of joint spatiotemporal risk patterns for Human Immunodeficiency Virus (HIV) and Tuberculosis (TB) in Kenya.
    PLoS One. 2026;21:e0352668.
    

    >> Share

    
    
44. SEJIE GA, Lebang T, Ngole G, Dichabe O, et al
    Determinants and predictive modelling of barriers to HIV testing uptake among adolescents and young adults in a private higher education institution in Botswana.
    PLoS One. 2026;21:e0352165.
    

    >> Share

    
    
45. KITIMBO J, Buregyeya E, Mutole G, Paul Ibanda J, et al
    Inpatient mortality and associated clinical factors among people living with HIV with cryptococcal meningitis in Uganda: A retrospective cohort study.
    PLoS One. 2026;21:e0340951.
    

    >> Share

    
    
46. ORDONEZ H, Ordonez CC, Gonzalez-Sanabria JS
    Artificial intelligence-based prediction of diseases among homeless populations in Bogota: Implications for targeted interventions.
    PLoS One. 2026;21:e0352268.
    

    >> Share

    
    
47. SALAS-ORTIZ A, Opuni M, Figueroa JL, Banda LM, et al
    Personality traits and the managerial capacity of community-based facilities providing HIV services to key populations in Kenya and Malawi.
    PLoS One. 2026;21:e0352752.
    

    >> Share

    
    
48. DILNESSA T, Moges F, Tessema B, Hailu W, et al
    Rifampicin resistance and associated factors of Mycobacterium tuberculosis among pulmonary tuberculosis-suspected patients in the Amhara National Regional State Comprehensive Specialized Hospitals, Ethiopia.
    PLoS One. 2026;21:e0351964.
    

    >> Share

    
    
49. YIMSAARD P, Lancaster KE, Ratchatasitthigul T, Janamnuaysook R, et al
    Cannabis use, sexual behaviors, and HIV prevention behaviors among young adults attending key-population-led sexual health clinics in Bangkok, Thailand: A mixed-method study.
    PLoS One. 2026;21:e0352395.
    

    >> Share

    
    
50. EFFAH K, Ametefe DL, Amuah JE, Essel NOM, et al
    A collaborative cervical precancer screening strategy with concurrent HPV genotyping and visual inspection using alumni of a training centre across Ghana: The Rotary 'Protect Your Pearl' initiative.
    PLoS One. 2026;21:e0350573.
    

    >> Share

    
    

    
    PLoS Pathog

51. TIAN M, Davis J, Cheng HL, Thompson LM, et al
    Maturation of HIV-1 neutralizing antibodies in a germinal center conditional expression mouse model.
    PLoS Pathog. 2026;22:e1014373.
    

    >> Share

    
    

    
    Virology

52. WEI W, Zhou Y, Ma Y, Yang Z, et al
    Generation and evaluation of an EcoHIV mouse model to study HIV-1 integration and expression.
    Virology. 2026;623:110991.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share